查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830639

人工胰臟裝置系統市場（按組件、適應症、設備類型、銷售管道、最終用戶和用戶分類）—2025-2032 年全球預測

Artificial Pancreas Device System Market by Component, Indication, Device Type, Sales Channel, End User, User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工胰臟裝置系統市場將成長至 6.8627 億美元，複合年成長率為 8.66%。

主要市場統計數據
基準年2024年 3.5311億美元
預計2025年 3.8164億美元
預測年份：2032年 6.8627億美元
複合年成長率（%） 8.66%

全面的介紹，展示監測、交付和演算法的融合將如何影響糖尿病護理的臨床採用途徑和相關人員的合作

本執行摘要首先重點介紹人工胰腺裝置系統生態系統，概述其臨床原理、技術組件以及推動其發展的監管和商業性力量之間的相互作用。該技術整合了持續血糖監測、胰島素傳輸硬體和先進的控制演算法，可實現需要胰島素的糖尿病患者的血糖管理自動化。臨床結果、患者易用性、互通性標準和長期依從性仍然是臨床效用和商業性應用的關鍵決定因素。

其中包括臨床醫生檢驗安全性和有效性，付款方定義報銷途徑，監管機構制定性能和網路安全標準，以及製造商最佳化成本、可製造性和服務模式。同時，現實世界證據和迭代軟體更新擴大為迭代設備核准和上市後監測提供資訊。這種融合將影響短期臨床應用和長期醫療服務模式的轉變，其中與遠端醫療、遠端監控和數據驅動的患者管理的整合將成為價值創造和系統永續性的核心。

本介紹為詳細分析技術曲折點、政策變化、市場進入動態和競爭定位奠定了基礎。

技術融合和監管適應推動感測器精度、預測控制演算法和穿戴式外形規格的進步，重新定義糖尿病管理

在感測保真度、演算法智慧和人因工程學的推動下，人工胰臟裝置系統格局正經歷一場變革。感測器精度的提高和佩戴時間的延長降低了訊號雜訊和校準負擔。因此，演算法設計正在從簡單的比例方法轉向基於模型的預測控制框架，該框架可以預測血糖值升高並即時調整給藥方案。

同時，裝置外形規格正在從笨重的手持式控制器演變為整合式穿戴裝置和謹慎的貼片解決方案，這些方案優先考慮患者的舒適度和依從性。這種硬體小型化，加上改進的設備間通訊標準和雲端分析功能，正在實現無縫遠端監控和持續學習系統，從而改善臨床決策支援。監管模式正在適應這種軟體主導的創新，並制定了應對迭代演算法更新、真實世界證據要求和更嚴格的網路安全預期的途徑。

這種轉變不僅會改善臨床結果，還會改變商業模式，激勵製造商將設備與服務、數據分析和病人參與平台捆綁在一起，以增強長期保留和差異化獎勵提案。

新的關稅現實正在推動供應鏈重組和商業模式重新調整，推動在地化、雙重採購和以服務為中心的定價策略

2025年新關稅的實施，迫使人工胰臟設備價值鏈上的相關人員重新評估供應鏈的彈性和成本結構。由於感測器、微電子裝置和胰島素輸送裝置等組件通常來自多個地區，進口關稅的變化將影響供應商資質、庫存緩衝和近岸外包選項的決策。製造商已採取應對措施，加快關鍵次組件的本地化，並探索替代採購管道，以緩解利潤率壓縮。

為了應對關稅主導的成本壓力，定價策略已從固定產品定價轉向包含服務的模式，透過訂閱式遠端監控和軟體維護協議攤銷設備成本。這種方法既能確保最終用戶的收益，又能為供應商保留經常性收入。此外，製造商加強了與當地政策制定者和行業協會的合作，以明確關稅分類，並爭取對公共衛生必需的醫療設備和零件獲得豁免。

在營運方面，企業優先考慮雙重籌資策略和策略性庫存佈局，以最大程度地減少臨床供應中斷。臨床試驗申辦方和醫院採購團隊也調整了訂單順序，以應對延長的前置作業時間，報銷分析師也修改了成本效益評估，將調整後的採購成本納入考慮。因此，關稅動態引發了更廣泛的重新評估，即如何在更具保護主義色彩的貿易環境中實現供應安全、合規性和永續定價。

多維、細分主導的觀點底層技術、臨床適應症、設備架構、銷售管道、醫療保健環境和人口統計數據與策略重點連結起來

從細分市場分析中獲得的見解揭示了組件選擇、臨床適應症、設備架構、銷售管道、最終用戶偏好和人口統計群體如何影響產品設計和上市優先順序。控制演算法如今涵蓋模型預測控制和比例積分微分方法，每種方法都需要量身定做的檢驗策略。顯示設備種類繁多，從傳統的手持設備到穿戴式顯示器，影響人為因素測試和連接性要求。胰島素泵包括貼片幫浦、導管泵和無導管泵，每種泵都涉及不同的服務和保固考慮因素。

擁有有效策略的公司優先考慮對 1 型和 2 型糖尿病患者進行更嚴格的血糖控制和自動化胰島素輸送。設備類型的細分——封閉式、混合封閉式和開迴路——反映了不同的自動化和監管水平，影響臨床試驗設計和監測強度。直銷、經銷商和線上零售商的銷售管道策略影響利潤結構和通路衝突管理，而診斷中心、居家照護機構、醫院和醫學研究實驗室的最終用戶細分則影響培訓、服務交付和保固服務。使用者人口統計分為成人和小兒科，成人細分進一步細分為中年、老年和青年人，小兒科細分為青少年和兒童。

這些子群體決定了人體工學、劑量演算法和依從性支持機制。總體而言，此細分框架支援產品優先順序、有針對性的臨床證據生成以及差異化行銷方法，使價值提案與不同相關人員群體的需求保持一致。

區域重要性影響美洲、歐洲、中東和非洲以及亞太市場的監管事務、報銷模式和供應鏈策略

區域促進因素對美洲、歐洲、中東和非洲以及亞太市場的監管時間表、報銷途徑、臨床實踐模式和供應鏈設計的影響各不相同。在美洲，清晰的監管和成熟的報銷框架促進了專科中心的快速採用，而私人付款人模式和整合的醫療體系則為基於訂閱的服務提供和捆綁式醫療安排創造了機會。美洲的臨床實踐強調基於結果的報銷和大型註冊系統，並進行上市後監測和迭代演算法改進。

中東和非洲的法規環境差異龐大，核准集中，各國報銷政策有差異。製造商必須應對複雜的醫療技術評估 (HTA) 流程和多樣化的臨床指南，從而製定量身定做的打入市場策略並產生本地化的證據。同時，亞太地區的特點是都市區快速採用技術，而其他市場則以成本驅動為導向。供應鏈考量在亞太地區尤其重要，因為製造群在提供規模經濟效益的同時，也使企業面臨區域貿易政策變化和零件採購風險。

在每個地區，與臨床網路、付款人和公共衛生當局的合作對於擴大採用至關重要，而製定特定區域價值提案、證據包和經銷夥伴關係的製造商將處於有利地位，可以加速臨床整合和商業性吸引力。

競爭定位由整合設備生態系統、軟體領先和加速證據生成和市場進入的策略夥伴關係參與企業

人工胰臟設備和系統領域的關鍵競爭動態反映了現有醫療設備公司、新興數位健康挑戰者以及專業組件供應商之間的拉鋸戰。市場領導企業透過整合產品系列實現差異化，這些產品組合將高保真感測器與強大的胰島素幫浦和複雜的控制演算法相結合；而挑戰者則通常專注於軟體優先的方法，改造現有硬體或提供增強傳統設備的演算法疊加。專注於電子機械系統、生物相容性黏合劑和安全通訊模組的組件供應商發揮戰略作用，他們使設計更緊湊、更耐用，並符合安全和資料完整性法規。

策略活動以夥伴關係和收購為中心，旨在加快檢驗系統的上市時間，保護核心演算法方法的智慧財產權，並擴展臨床證據庫。各公司也正在投資上市後數據平台和付款人合作夥伴關係，以證明其在實際應用中的成本效益。競爭定位越來越依賴不僅提供可靠的設備，還提供培訓、遠端監控服務和數據分析的生態系統，以幫助客製化個人化治療。

隨著競爭的成熟，透過使用者體驗、互通性和售後服務實現差異化將變得與效能指標同樣重要，而那些在以患者為中心的設計和可擴展服務交付方面表現出色的公司將更有可能保持競爭優勢。

領導者可採取的策略重點是將感測器創新、模組化產品藍圖、彈性供應鏈和混合定價結合起來，以釋放持久的臨床和商業性價值

產業領導者應採取一致的策略，在技術創新、切實可行的商業化和供應彈性之間取得平衡。他們應優先投資高精度感測技術和模型預測控制演算法，這些演算法能夠證明血糖結果的改善，並簡化檢驗路徑。同時，他們在設計產品藍圖時應考慮模組化，使硬體平台能夠支援迭代式軟體改進和新的演算法功能，而無需完全更換硬體。

從商業性角度來看，我們將推行混合定價模式，將領先與監管機構和付款方合作，共同製定證據生成計劃，使臨床試驗終點與報銷標準相一致，並投資於真實世界數據收集，以支持上市後索賠和重複核准。

最後，將以患者為中心的設計融入每個開發階段，讓成人和兒童終端用戶參與可用性測試，並為臨床醫生、居家照護護理人員和診斷中心量身定做培訓計劃，這將加速產品採用並減少培訓阻力。這些舉措使企業能夠將技術優勢轉化為永續的臨床和商業性成果。

採用嚴格的混合方法研究途徑，結合專家訪談、設備能力映射、監管分析和情境規劃來檢驗可行的見解

本分析背後的調查方法融合了定性和定量分析，以確保獲得可靠且可複製的見解。主要研究包括對不同醫療機構的臨床專家、設備工程師、監管專業人員和採購主導者進行結構化訪談，以收集安全性、可用性和採用障礙的經驗知識。次要研究整合了同行評審的臨床文獻、監管指導文件以及已發布的設備互通性和網路安全標準，以彙編技術和政策趨勢。

分析方法包括比較設備能力映射，以識別控制演算法、感測器和交付機制之間的能力差距，以及情境分析，以評估供應鏈對關稅變化和採購衝擊的反應。證據三角檢驗透過將關鍵輸入與監管備案文件、臨床試驗註冊和公共公告進行交叉引用，檢驗了研究結果。在適用的情況下，我們考慮了可用性和人為因素，透過案例研究和最終用戶回饋循環，將技術性能與日常患者體驗聯繫起來。

這種多層次的方法確保策略結論是基於多種證據和平衡的技術特性以及市場進入、法規遵循和臨床應用的實際考慮。

策略綜合強調需要綜合臨床證據、以病人為中心的設計和靈活的商業模式，以廣泛部署技術潛力

總而言之，人工胰臟系統代表了糖尿病照護領域的關鍵進步，這得益於感測器可靠性的提升、演算法的複雜度以及穿戴式工程技術的進步。更廣泛的臨床應用不僅取決於其卓越的血糖控制效果，還取決於將報銷、供應鏈設計和使用者體驗與臨床實踐和患者生活方式的實際情況相結合。貿易動態和政策變化表明，供應鏈的韌性和靈活的商業模式與技術能力同等重要。

展望未來，整合嚴謹臨床證據生成、以患者為中心的設計和靈活商業結構的相關人員，將有望勝過僅專注於單一技術改進的競爭對手。設備製造商、零件供應商、臨床醫生、付款人和監管機構之間的協作，對於協調標準、加快核准和確保公平可及性仍然至關重要。最終，成功的設備將結合可證實的臨床效益、無縫的使用者體驗和永續的經營模式，以支援長期患者參與和醫療系統整合。

這種整合凸顯了整個生態系統協調行動的必要性，以將技術前景轉化為持續的臨床影響和可擴展的商業性成果。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 提高機器學習演算法的整合度，以提供個人化的胰島素劑量建議
  • 擴大採用將 CGM 數據與自動胰島素輸送相結合的混合封閉回路型系統
  • 擴展基於智慧型手機的人工胰腺應用程式，用於即時血糖監測和控制
  • 開發一種能夠輸送胰島素和升糖素的雙激素系統來改善血糖值穩定性
  • 增加對支援第三方 CGM 和泵浦整合的可互通設備生態系統的投資
  • 生物相容性感測器塗層的進步提高了連續血糖監測儀的壽命和準確性

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 人工胰臟裝置系統市場（依組件）

  • 控制演算法
    • 模型預測控制
    • 比例-積分-微分控制
  • 顯示裝置
    • 傳統手持裝置
    • 穿戴式顯示裝置
  • 胰島素幫浦
    • 貼片幫浦
    • 管泵
    • 無內胎幫浦
  • 感應器
    • 葡萄糖感測器
    • 胰島素感測器

9. 人工胰臟裝置系統市場（按適應症）

  • 1型糖尿病
  • 2型糖尿病

第 10 章。人工胰臟設備系統市場（依設備類型）

  • 封閉回路型系統
  • 混合封閉回路型系統
  • 開放回路系統

第 11 章人工胰臟裝置系統市場（依銷售管道）

  • 直銷
  • 經銷商
  • 線上零售商

第 12 章。人工胰臟裝置系統市場（按最終用戶）

  • 診斷中心
  • 居家照護環境
  • 醫院
  • 醫學研究所

第 13 章：人工胰臟裝置系統市場（按使用者）

  • 成人
    • 中年人
    • 老年人
    • 年輕人
  • 孩子們
    • 青年
    • 孩子

第 14 章。按地區分類的人工胰臟裝置系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章人工胰臟裝置系統市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章。人工胰臟裝置系統市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Beta Bionics, Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom, Inc.
    • Diabeloop SA
    • DreaMed Diabetes Ltd.
    • Eli Lilly and Company
    • Glytec, LLC
    • Inreda Diabetic BV
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic PLC
    • NIKKISO Co., Ltd.
    • Pancreum, Inc.
    • Renfrew Group International
    • Securecell AG
    • Senseonics Holdings, Inc.
    • Sequel Med Tech, LLC
    • Tandem Diabetes Care, Inc.
    • The Menarini Group
Product Code: MRR-4369010658A1

The Artificial Pancreas Device System Market is projected to grow by USD 686.27 million at a CAGR of 8.66% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 353.11 million
Estimated Year [2025] USD 381.64 million
Forecast Year [2032] USD 686.27 million
CAGR (%) 8.66%

A comprehensive orientation that frames the convergence of monitoring, delivery, and algorithms shaping clinical adoption pathways and stakeholder alignment across diabetes care

This executive summary opens with a focused orientation to the artificial pancreas device system ecosystem, outlining the clinical rationale, technological building blocks, and the interplay of regulatory and commercial forces that are driving its evolution. The technology converges continuous glucose monitoring, insulin delivery hardware, and advanced control algorithms to automate glycemic management for people with insulin-requiring diabetes. Clinical outcomes, patient usability, interoperability standards, and long-term adherence remain the primary determinants of clinical utility and commercial uptake.

Moving from concept to mainstream care requires alignment across stakeholders: clinicians who validate safety and efficacy, payers who define reimbursement pathways, regulators who set performance and cybersecurity standards, and manufacturers who optimize cost, manufacturability, and service models. In parallel, real-world evidence and iterative software updates increasingly inform iterative device approvals and post-market surveillance. This convergence shapes both near-term clinical adoption and longer-term shifts in care delivery, where integration with telehealth, remote monitoring, and data-driven patient management becomes central to value creation and system sustainability.

This introduction sets the stage for an in-depth analysis of technological inflection points, policy changes, market access dynamics, and competitive positioning explored in the subsequent sections.

Technological convergence and regulatory adaptation driving sensor precision, predictive control algorithms, and wearable form factor evolution to redefine diabetes management

The landscape for artificial pancreas device systems is undergoing transformative shifts driven by advances in sensing fidelity, algorithmic intelligence, and human factors engineering. Sensor accuracy improvements and longer wear-time profiles have reduced signal noise and calibration burden, which in turn permits control algorithms to operate with higher confidence and more aggressive insulin titration strategies. As a result, algorithm design has shifted from simple proportional approaches to model-based predictive control frameworks that anticipate glycemic excursions and adapt delivery profiles in real time.

Concurrently, device form factors have evolved from bulky handheld controllers to integrated wearables and discreet patch solutions that emphasize patient comfort and adherence. This hardware miniaturization, coupled with improved inter-device communication standards and cloud-enabled analytics, enables seamless remote monitoring and continuous learning systems that refine clinical decision support. Regulatory paradigms are adapting to this software-driven innovation, with pathways that accommodate iterative algorithm updates, real-world evidence requirements, and stricter cybersecurity expectations.

Taken together, these shifts not only improve clinical outcomes but also alter commercial models, incentivizing manufacturers to bundle devices with services, data analytics, and patient engagement platforms that reinforce long-term retention and differentiated value propositions.

Supply chain realignment and commercial model recalibration triggered by new tariff realities, prompting localization, dual sourcing, and service-focused pricing strategies

The imposition of new tariff measures in 2025 has compelled stakeholders to reassess supply chain resilience and cost structures across the artificial pancreas device system value chain. Components such as sensors, microelectronics, and insulin delivery mechanisms are frequently sourced across multiple geographies; therefore, changes in import duties influence decisions on supplier qualification, inventory buffering, and nearshoring alternatives. Manufacturers responded by accelerating localization of critical subassemblies and seeking alternative procurement lanes to mitigate margin compression.

In response to tariff-driven cost pressures, pricing strategies have shifted from flat product pricing toward service-inclusive models that amortize device costs over subscription-based remote monitoring and software maintenance contracts. This approach preserves affordability for end users while maintaining recurring revenue for suppliers. Additionally, manufacturers intensified engagements with local policymakers and trade associations to clarify tariff classifications and to pursue exemptions for medical devices and components essential to public health.

Operationally, firms prioritized dual-sourcing strategies and strategic inventory positioning to minimize disruption to clinical supply. Clinical trial sponsors and hospital procurement teams also adjusted ordering cadences to account for extended lead times, while reimbursement analysts revisited cost-effectiveness assessments to incorporate adjusted procurement costs. As a result, tariff dynamics catalyzed a broader reassessment of how to achieve supply security, regulatory compliance, and sustainable pricing in a more protectionist trade environment.

A multidimensional segmentation-driven perspective that links component technologies, clinical indications, device architectures, sales channels, care settings, and age cohorts to strategic priorities

Insights derived from segment-level analysis reveal how component choices, clinical indication, device architecture, sales channels, end user settings, and demographic cohorts collectively shape product design and go-to-market priorities. Component-level distinctions between control algorithms, display devices, insulin pumps, and sensors drive distinct engineering and regulatory pathways: control algorithms now span model predictive control and proportional integral derivative approaches, each demanding tailored validation strategies; display devices range from traditional handheld units to wearable displays, influencing human factors testing and connectivity requirements; insulin pumps encompass patch pumps, tubed pumps, and tubeless pumps, creating different servicing and warranty considerations; and sensors include glucose sensors and emerging insulin sensors, each with unique calibration and lifespan characteristics.

Indication-specific dynamics differentiate pathways for Type 1 and Type 2 diabetes populations, with Type 1 patients often prioritizing tighter glycemic control and automated insulination, while Type 2 cohorts may demand simpler hybrid solutions integrated with lifestyle management support. Device type segmentation-closed loop systems, hybrid closed loop systems, and open loop systems-reflects varying levels of automation and regulatory scrutiny, affecting clinical trial design and monitoring intensity. Sales channel strategies across direct sales, distributors, and online retailers influence margin structures and channel conflict management, while end user segmentation spanning diagnostic centers, homecare settings, hospitals, and medical research institutes informs training, service delivery, and warranty provisioning. User demographics distinguish adults and pediatrics, with adults further segmented into middle-aged, older, and young adults, and pediatrics split into adolescents and children; these subgroups dictate ergonomics, dosing algorithms, and adherence support mechanisms.

Collectively, this segmentation framework supports product prioritization, targeted clinical evidence generation, and differentiated marketing approaches that align value propositions with the needs of distinct stakeholder groups.

Distinct regional imperatives shaping regulatory pathways, reimbursement models, and supply chain strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics exert distinct influences on regulatory timelines, reimbursement pathways, clinical practice patterns, and supply chain design across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, regulatory clarity and established reimbursement frameworks facilitate rapid adoption in specialized centers, while private payer models and integrated health systems create opportunities for subscription-based service offerings and bundled care arrangements. Clinical practice in the Americas emphasizes outcome-driven reimbursement and large-scale registries that support post-market surveillance and iterative algorithm refinement.

Europe Middle East & Africa presents heterogeneous regulatory environments where centralized approvals coexist with country-level reimbursement variability. Manufacturers navigate complex HTA processes and varying clinical guideline adoption, which necessitates tailored market entry strategies and localized evidence generation. Meanwhile, the Asia-Pacific region demonstrates a dynamic mix of rapid technology adoption in urban centers and cost-sensitive procurement in other markets. Supply chain considerations are particularly salient in Asia-Pacific, where manufacturing clusters offer scale advantages but also expose firms to regional trade policy shifts and component sourcing risks.

Across all regions, collaborations with clinical networks, payers, and public health authorities prove pivotal for scaling adoption, and manufacturers that craft region-specific value propositions, evidence packages, and distribution partnerships are better positioned to accelerate clinical integration and commercial traction.

Competitive positioning shaped by integrated device ecosystems, software-first entrants, and strategic partnerships that accelerate evidence generation and market access

Key competitive dynamics in the artificial pancreas device system arena reflect a tug-of-war between established medical device companies, emergent digital health challengers, and specialized component suppliers. Market leaders differentiate through integrated product portfolios that marry high-fidelity sensors with robust insulin pumps and sophisticated control algorithms, while challenger firms often focus on software-first approaches that retrofit existing hardware or offer algorithmic overlays to enhance legacy devices. Component suppliers specializing in microelectromechanical systems, biocompatible adhesives, and secure communication modules play a strategic role by enabling design miniaturization, extended wear times, and regulatory compliance for safety and data integrity.

Strategic activity centers on partnerships and acquisitions that accelerate time-to-market for validated systems, secure intellectual property in core algorithmic approaches, and broaden clinical evidence libraries. Companies are also investing in post-market data platforms and partnerships with payers to demonstrate cost-effectiveness in real-world settings. Competitive positioning increasingly hinges on the ability to deliver not only a reliable device but an ecosystem that includes training, remote monitoring services, and data analytics that inform personalized therapy adjustments.

As competition matures, differentiation by user experience, interoperability, and after-sales service becomes as consequential as performance metrics, and firms that excel in patient-centric design and scalable service delivery will likely sustain a competitive advantage.

Actionable strategic priorities for leaders to combine sensor innovation, modular product roadmaps, resilient supply chains, and hybrid pricing to unlock durable clinical and commercial value

Industry leaders should adopt a cohesive strategy that balances technological innovation with pragmatic commercialization and supply resilience. Prioritize investment in high-accuracy sensing technologies and model predictive control algorithms that demonstrably improve glycemic outcomes while streamlining validation pathways. Concurrently, design product roadmaps that account for modularity so that hardware platforms can support iterative software improvements and new algorithmic capabilities without requiring full hardware replacements.

From a commercial perspective, pursue hybrid pricing models that blend up-front device pricing with subscription services for remote monitoring, clinical support, and software maintenance to preserve margins while improving patient affordability. Strengthen supplier diversification and nearshoring where feasible to reduce exposure to tariff-induced volatility, and develop contingency inventory strategies that limit clinical disruption. Engage early with regulators and payers to co-design evidence generation plans that align clinical trial endpoints with reimbursement criteria, and invest in real-world data collection to support post-market claims and iterative approvals.

Finally, embed patient-centered design into every stage of development by involving adult and pediatric end users in usability testing, and create educational programs tailored to clinicians, homecare providers, and diagnostic centers to accelerate adoption and reduce training friction. These actions will help organizations convert technical gains into sustainable clinical and commercial outcomes.

A rigorous mixed-methods research approach combining expert interviews, device feature mapping, regulatory analysis, and scenario planning to validate actionable insights

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research involved structured interviews with clinical experts, device engineers, regulatory specialists, and procurement leads across diverse care settings to capture experiential knowledge about safety, usability, and adoption barriers. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance documents, and published standards for device interoperability and cybersecurity to contextualize technological and policy trends.

Analytical methods included comparative device feature mapping to identify capability differentials among control algorithms, sensors, and delivery mechanisms, as well as scenario analysis to evaluate supply chain responses to tariff changes and procurement shocks. Evidence triangulation validated findings by cross-referencing primary input with regulatory filings, clinical trial registries, and public policy announcements. Where applicable, usability and human factors considerations were assessed through case studies and end-user feedback loops to connect technical performance with day-to-day patient experience.

This layered methodology ensures that strategic conclusions rest on multiple lines of evidence, balancing technical specificity with pragmatic considerations for market access, regulatory compliance, and clinical adoption.

A strategic synthesis emphasizing the need for integrated clinical evidence, patient-focused design, and resilient commercial models to convert technological promise into widespread adoption

In conclusion, artificial pancreas device systems represent a pivotal advance in diabetes care, enabled by improvements in sensor reliability, algorithm sophistication, and wearable engineering. The pathway to wider clinical adoption depends not only on demonstrating superior glycemic control but also on aligning reimbursement, supply chain design, and user experience with the practical realities of clinical practice and patient lifestyles. Trade dynamics and policy shifts have shown how supply chain resilience and adaptable commercial models are as critical as technological competency.

Moving forward, stakeholders that integrate rigorous clinical evidence generation, patient-centered design, and flexible commercial constructs will outpace competitors that focus solely on isolated technological improvements. Collaboration among device manufacturers, component suppliers, clinicians, payers, and regulators remains essential to harmonize standards, accelerate approvals, and ensure equitable access. Ultimately, the devices that succeed will be those that combine demonstrable clinical benefit with seamless user experiences and sustainable business models that support long-term patient engagement and health system integration.

This synthesis underscores the imperative for coordinated action across the ecosystem to translate technological promise into durable clinical impact and scalable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising integration of machine learning algorithms for personalized insulin dosing recommendations
  • 5.2. Increased adoption of hybrid closed loop systems combining CGM data with automated insulin delivery
  • 5.3. Expansion of smartphone-based artificial pancreas apps for real-time glucose monitoring and control
  • 5.4. Development of dual-hormone systems administering insulin and glucagon for improved glycemic stability
  • 5.5. Growing investment in interoperable device ecosystems supporting third-party CGM and pump integration
  • 5.6. Advances in biocompatible sensor coatings to extend continuous glucose monitor lifespan and accuracy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Pancreas Device System Market, by Component

  • 8.1. Control Algorithms
    • 8.1.1. Model Predictive Control
    • 8.1.2. Proportional Integral Derivative Control
  • 8.2. Display Devices
    • 8.2.1. Traditional Handheld Devices
    • 8.2.2. Wearable Display Devices
  • 8.3. Insulin Pumps
    • 8.3.1. Patch Pumps
    • 8.3.2. Tubed Pumps
    • 8.3.3. Tubeless Pumps
  • 8.4. Sensors
    • 8.4.1. Glucose Sensors
    • 8.4.2. Insulin Sensors

9. Artificial Pancreas Device System Market, by Indication

  • 9.1. Type 1 Diabetes
  • 9.2. Type 2 Diabetes

10. Artificial Pancreas Device System Market, by Device Type

  • 10.1. Closed Loop Systems
  • 10.2. Hybrid Closed Loop Systems
  • 10.3. Open Loop Systems

11. Artificial Pancreas Device System Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Retailers

12. Artificial Pancreas Device System Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Homecare Settings
  • 12.3. Hospitals
  • 12.4. Medical Research Institutes

13. Artificial Pancreas Device System Market, by User

  • 13.1. Adults
    • 13.1.1. Middle-Aged Adults
    • 13.1.2. Older Adults
    • 13.1.3. Young Adults
  • 13.2. Pediatrics
    • 13.2.1. Adolescents
    • 13.2.2. Children

14. Artificial Pancreas Device System Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Artificial Pancreas Device System Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Pancreas Device System Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Beta Bionics, Inc.
    • 17.3.4. Bigfoot Biomedical Inc.
    • 17.3.5. Dexcom, Inc.
    • 17.3.6. Diabeloop SA
    • 17.3.7. DreaMed Diabetes Ltd.
    • 17.3.8. Eli Lilly and Company
    • 17.3.9. Glytec, LLC
    • 17.3.10. Inreda Diabetic B.V.
    • 17.3.11. Insulet Corporation
    • 17.3.12. Johnson & Johnson
    • 17.3.13. Medtronic PLC
    • 17.3.14. NIKKISO Co., Ltd.
    • 17.3.15. Pancreum, Inc.
    • 17.3.16. Renfrew Group International
    • 17.3.17. Securecell AG
    • 17.3.18. Senseonics Holdings, Inc.
    • 17.3.19. Sequel Med Tech, LLC
    • 17.3.20. Tandem Diabetes Care, Inc.
    • 17.3.21. The Menarini Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA ARTIFICIAL PANCREAS DEVICE